Milan criteria
Milan criteria is a set of criteria used to determine the suitability of a patient with HCC for liver transplant. The criteria were established in Milan, Italy, hence the name.
History[edit | edit source]
The Milan criteria were first proposed in 1996 by a team of researchers led by Massimo Colombo. The team conducted a study on patients with HCC who underwent liver transplantation and found that those who met the criteria had a significantly better survival rate.
Criteria[edit | edit source]
The Milan criteria include the following:
- One liver tumor that is 5 cm or smaller in diameter.
- Up to three liver tumors, none larger than 3 cm.
- No evidence of cancer spread outside the liver.
Use[edit | edit source]
The Milan criteria are widely used around the world to determine the eligibility of patients with HCC for liver transplantation. They are endorsed by the WHO and the AASLD.
Criticism[edit | edit source]
Some critics argue that the Milan criteria are too restrictive and exclude many patients who could benefit from a liver transplant. In response to this criticism, several alternative criteria have been proposed, including the UCSF criteria and the Up-to-seven criteria.
See also[edit | edit source]
- Liver transplantation
- Hepatocellular carcinoma
- Liver tumor
- Cancer metastasis
- World Health Organization
- American Association for the Study of Liver Diseases
- UCSF criteria
- Up-to-seven criteria
Milan criteria Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Admin, Prab R. Tumpati, MD